Basic product information

Brand names and availability can vary. In the UK, medicines are typically supplied via NHS services or private pharmacies, depending on patient needs and local supply arrangements.

How Prandin works (mechanism of action)

Repaglinide is part of the meglitinide family of diabetes medicines. It works by:

• Binding to specific receptors on pancreatic beta cells (cells that produce insulin).
• Triggering insulin release when blood sugar rises (especially after you eat).
• Helping reduce post-meal glucose by increasing insulin at the right time.

Because the insulin release is closely linked to meals, Prandin is often described as having a rapid onset and a shorter action around meals compared with some other tablet options.

Pharmacokinetics (what the body does to the medicine)

Pharmacokinetics describes how the body absorbs, distributes, metabolises, and eliminates a medicine. Key points for repaglinide include:

• Absorption: Repaglinide is absorbed from the gut, with effects beginning relatively soon after a dose.
• Peak effect: Blood levels rise quickly and help lower blood sugar after meals.
• Metabolism: It is largely processed by the liver (primarily via the enzyme CYP3A4).
• Elimination: Metabolites are eliminated mainly via bile/faeces and to a lesser extent in urine.
• Clinical implication: Liver function and certain drug interactions can significantly affect how repaglinide behaves in the body.

Your prescriber may adjust dosing based on your blood glucose pattern, age, kidney/liver function, and the medicines you already take.

What Prandin is used for (typical use & indications)

Prandin is used in adults with type 2 diabetes to improve blood glucose control. It is particularly useful for people who need help controlling blood sugar after meals.

In some treatment plans, repaglinide may be used:

• As monotherapy (alone) when diet, exercise, and/or metformin are not appropriate.
• In combination therapy with other diabetes medicines, depending on individual needs.

Your exact plan will be based on HbA1c results, home blood glucose readings, meal timing, and risk of low blood sugar.

When to take it (timing around meals)

Prandin works best when taken in relation to meals. The usual timing is:

• Take a dose before meals—often within about 15 minutes before eating (your clinician may advise a specific window).
• If you miss a meal, do not take a dose for that meal unless your clinician has told you otherwise.
• It is commonly taken up to three times daily, before the main meals.

Because the medicine is meal-linked, consistent eating patterns can help reduce fluctuations in glucose. If your meals are unpredictable, talk to your prescriber about the safest schedule for you.

Dosing (general guidance)

Dosing must be individualised. The information below is general and not a substitute for advice from a healthcare professional.

Starting dose and adjustments

• Your clinician will choose a starting dose based on your current diabetes control, age, and previous medicines.
• Doses are usually adjusted gradually according to your blood glucose readings and HbA1c results.
• If you switch from another glucose-lowering medicine, the timing and starting dose may differ.

Typical number of doses

Many patients take repaglinide before each main meal (often up to three times daily). The exact schedule depends on how many meals you eat each day.

Missed dose

• If you miss a dose, take it only if it is still before a meal.
• If you are already within the meal or after it, follow your clinician’s guidance.
• Do not double up to make up for a missed dose.

If you are unsure about your dose schedule, check your medicine label and speak to your pharmacist.

Food interactions and meal-related considerations

Food is central to how Prandin is used. Important points include:

• Take Prandin before meals as directed. The medicine’s glucose-lowering effect is linked to meal-related insulin release.
• Eating less than usual (smaller portions or skipped meals) may increase the chance of low blood sugar (hypoglycaemia).
• Large, carbohydrate-heavy meals may still cause a glucose rise even with repaglinide, though it should be reduced. Regular monitoring helps guide safe adjustments.
• A stable meal pattern and consistent carbohydrate intake can improve predictability of blood sugar levels.

If you change your diet (e.g., due to weight loss, religious fasting, or a reduced appetite), inform your healthcare team so your diabetes plan can be reviewed.

Alcohol and medicine interactions

Alcohol

Alcohol can affect blood sugar in several ways and can increase the risk of hypoglycaemia—especially if you drink without eating. Alcohol may also interfere with diabetes self-care and symptom awareness.

• Avoid drinking on an empty stomach.
• If you choose to drink, do so with food and monitor your blood sugar more frequently.
• Be aware that low blood sugar symptoms can be similar to feeling intoxicated.

Your clinician can give personalised advice based on your usual alcohol intake and overall health.

Key medicine interactions (what to check)

Repaglinide is metabolised mainly by CYP3A4. Medicines that strongly inhibit or induce CYP3A4 can change repaglinide blood levels and increase the risk of side effects or loss of effect.

Examples of interaction risks (not exhaustive) include:

• Strong CYP3A4 inhibitors may increase repaglinide levels and raise hypoglycaemia risk. Examples can include certain antifungals and some antibiotics (your pharmacist can check your exact medicines).
• CYP3A4 inducers may lower repaglinide levels and reduce its glucose-lowering effect. Examples can include some anti-seizure medicines and certain herbal products.
• Other glucose-lowering medicines (such as insulin or sulfonylureas) may increase the risk of hypoglycaemia when combined.
• Some medicines can affect kidney or liver function, indirectly influencing diabetes control and safety.

Always provide a complete list of medicines, including over-the-counter products and herbal supplements, when starting repaglinide or if you start something new.

Safety profile and common side effects

Like all medicines, Prandin (repaglinide) can cause side effects. Not everyone gets them. Some side effects are more important than others—particularly hypoglycaemia.

Most common / expected effects

• Low blood sugar (hypoglycaemia) is the key risk, especially if meals are skipped or doses are high.
• Possible headache, gastrointestinal upset, or general tiredness may occur in some people.

Hypoglycaemia (low blood sugar): symptoms and action

Hypoglycaemia can happen when blood glucose becomes too low. It is more likely if you:

• take repaglinide and eat less than usual or miss meals
• exercise more than planned
• take other glucose-lowering medicines
• have kidney or liver problems (dose may need review)
• drink alcohol

Common symptoms include:

• sweating, shakiness, feeling anxious
• hunger, nausea
• palpitations
• confusion, dizziness, difficulty concentrating
• in severe cases, fainting or loss of consciousness

What to do (general advice):

• Take a fast-acting source of sugar (e.g., glucose tablets or a sugary drink) if you feel symptoms.
• Recheck blood glucose if you are able.
• Once improved, eat a small snack if your next meal is not soon.
• If you become unconscious or severe symptoms occur, seek urgent medical help.

When to seek urgent help

Contact emergency services or seek urgent care if you suspect severe hypoglycaemia, or if you develop signs of a serious allergic reaction (such as swelling of the face/lips, breathing difficulties, or widespread rash).

Warnings and cautions

• Older adults: sensitivity to medicines and hypoglycaemia risk may be higher.
• Liver disease: because repaglinide is metabolised in the liver, dosing may need careful adjustment.
• Kidney disease: the risk of hypoglycaemia may increase, and monitoring is important.
• Irregular eating: if you often skip meals, repaglinide may not be the best option—discuss alternatives.

Practical tips for using Prandin effectively

• Match the dose to your meals: take it before the meal you are actually going to eat.
• Keep a routine: aim for consistent meal times and carbohydrate patterns where possible.
• Monitor your blood sugar: check readings as advised, especially when starting or changing dose.
• Know your thresholds: ask your healthcare team what blood glucose targets and “low” numbers mean for you.
• Carry fast sugar: glucose tablets or sugary sweets can help if you develop symptoms of hypoglycaemia.
• Plan for activity: exercise can lower glucose—consider monitoring before, during, and after activity.
• Medication list: keep an up-to-date list of your medicines and show it to healthcare professionals.
• Don’t stop suddenly without advice: changes to diabetes medicines should be guided by your clinician.

If you are unwell (e.g., infection, vomiting, reduced intake), seek guidance promptly because diabetes plans may need temporary changes.

Alternative options (if Prandin isn’t suitable)

There are several other treatments for type 2 diabetes in the UK. The best choice depends on your medical history, weight considerations, risk of hypoglycaemia, kidney function, and whether you prefer meal-linked dosing.

Oral options (tablets)

• Metformin (often first-line in many patients)
• Sulfonylureas (stimulate insulin release but may carry higher hypoglycaemia risk)
• DPP-4 inhibitors (help increase insulin after meals and reduce glucagon)
• SGLT2 inhibitors (help remove glucose via urine)
• Thiazolidinediones (improve insulin sensitivity; may have specific safety considerations)

Injectable options (non-insulin)

• GLP-1 receptor agonists (can aid weight and glucose control)
• Dual incretin therapies (depending on suitability and availability)

Insulin therapy

• Basal or bolus insulin regimens may be used when needed.

If you are experiencing frequent hypos, poor control, or practical difficulties with meal timing, ask your clinician or pharmacist whether another medicine could suit your lifestyle and risk profile.

UK market and legal context (what to expect)

Medicines in the UK are regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). Product availability, prescribing practices, and guidance may change over time. Pharmacies must comply with UK medicines legislation and safe dispensing requirements.

For people using diabetes medicines, it is important to follow the plan in place with healthcare professionals. Changes to supply or brand presentations (such as tablet strengths) may occasionally occur; confirm that you have the correct strength and dosing instructions.

Recent guidance and monitoring (general UK diabetes approach)

In the UK, diabetes management typically follows national and local recommendations and considers:

• Personalised treatment goals (including HbA1c targets adjusted for age, comorbidities, and hypoglycaemia risk).
• Structured education about diet, activity, glucose monitoring, and recognising hypos.
• Regular review of effectiveness and side effects.
• Cardiovascular and kidney risk management alongside glucose control.

Guidance evolves. If your regimen includes repaglinide, your clinician may review it periodically to ensure it remains the safest and most effective option for you.

Delivery and availability in the UK

Online pharmacies may offer delivery of medicines to eligible UK addresses. Availability can vary depending on local stock, strength, and manufacturer. When you place an order:

• Check the tablet strength and quantity to ensure it matches your dosing instructions.
• Allow time for processing and delivery, especially if a product needs replenishing.
• Use reliable delivery addresses and ensure someone is available if a signature is required.

If repaglinide is temporarily out of stock, reputable pharmacies will usually contact you with options such as alternatives, expected restock timing, or a substitution process where permitted and clinically appropriate.

If you have urgent needs or have had difficulty controlling your glucose, contact the pharmacy’s support team for the fastest solution.

FAQ – Frequently asked questions

1) What is Prandin used for?

Prandin (repaglinide) helps control blood glucose in adults with type 2 diabetes, mainly by stimulating insulin release around meal times to reduce post-meal sugar rises.

2) When should I take Prandin?

Take it before meals as advised on your label. Many patients take it within about 15 minutes before eating. If you skip a meal, you may be told not to take that dose—follow your clinician’s instructions.

3) What if I forget a dose?

If you forget and you have not yet eaten, you may be able to take it before that meal. If you are already past your meal, follow the guidance you were given (do not double up). If unsure, ask your pharmacist.

4) Can Prandin cause hypos?

Yes. Hypoglycaemia (low blood sugar) is a known risk with repaglinide, particularly if you take it but eat less than usual, miss meals, drink alcohol, exercise more, or combine with other diabetes medicines.

5) What should I do if I get symptoms of low blood sugar?

Take fast-acting sugar (such as glucose tablets or a sugary drink), then recheck your blood sugar if possible. If symptoms are severe or you cannot take sugar by mouth, seek urgent medical assistance.

6) Can I drink alcohol while taking Prandin?

Alcohol can increase the risk of low blood sugar, especially if you drink without eating. If you choose to drink, do so with food and monitor your glucose more carefully. Seek personalised advice from your healthcare team.

7) Are there important drug interactions?

Yes. Repaglinide is affected by liver enzymes (notably CYP3A4). Some antibiotics, antifungals, anti-seizure medicines, and other drugs may change repaglinide levels. Always tell your pharmacist about all medicines and supplements you take.

8) Does food interact with Prandin?

Food affects how Prandin is used. The medicine is intended to be taken immediately before meals. Skipping meals increases the risk of hypos.

9) Who should be extra careful?

People with kidney or liver problems, older adults, those with irregular eating patterns, and those who experience frequent hypos should be reviewed closely by their healthcare team.

10) Are there alternatives to Prandin?

Yes. Depending on your needs, clinicians may consider other tablet options (e.g., metformin, DPP-4 inhibitors, SGLT2 inhibitors, sulfonylureas), injectables (e.g., GLP-1 receptor agonists), or insulin. The best choice depends on your overall risk and lifestyle.

Important note

This page provides general information about Prandin (repaglinide). Your individual advice may differ based on your medical history, current medicines, and blood glucose targets. If you have questions about dosing, interactions, or side effects, speak to a pharmacist or healthcare professional.